Literature DB >> 11283792

The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.

J P Drenth1, W H Finley, G J Breedveld, L Testers, J J Michiels, G Guillet, A Taieb, R L Kirby, P Heutink.   

Abstract

Primary erythermalgia is a rare disorder characterized by recurrent attacks of red, warm, and painful hands and/or feet. The symptoms are generally refractory to treatment and persist throughout life. Five kindreds with multiple cases of primary erythermalgia were identified, and the largest was subjected to a genomewide search. We detected strong evidence for linkage of the primary erythermalgia locus to markers from chromosome 2q. The highest LOD score (Z) was obtained with D2S2330 (Z(max) = 6.51). Analysis of recombination events identified D2S2370 and D2S1776 as flanking markers, on chromosome 2q31-32. This defines a critical interval of 7.94 cM that harbors the primary erythermalgia gene. Affected members within the additional families also shared a common haplotype on chromosome 2q31-32, supporting our linkage results. Identification of the primary erythermalgia gene will allow a better clinical classification of this pleomorphic group of disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283792      PMCID: PMC1226108          DOI: 10.1086/320107

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

Review 2.  Primary and secondary erythermalgia, a critical review.

Authors:  J J Michiels; T van Joost
Journal:  Neth J Med       Date:  1988-12       Impact factor: 1.422

3.  Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia.

Authors:  C Mork; C L Asker; E G Salerud; K Kvernebo
Journal:  J Invest Dermatol       Date:  2000-04       Impact factor: 8.551

4.  [On the clinical features of erythromelalgia. Familial incidence of an idiopathic form in mother and daughter].

Authors:  A Krebs; H U Andres
Journal:  Schweiz Med Wochenschr       Date:  1969-03-15

5.  Erythromelalgia--not so benign.

Authors:  R L Kirby
Journal:  Arch Phys Med Rehabil       Date:  1987-06       Impact factor: 3.966

6.  Familial erythromelalgia.

Authors:  I J Cohen; C S Samorodin
Journal:  Arch Dermatol       Date:  1982-11

7.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

8.  Idiopathic erythermalgia: a congenital disorder.

Authors:  J J Michiels; T van Joost; V D Vuzevski
Journal:  J Am Acad Dermatol       Date:  1989-11       Impact factor: 11.527

9.  Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.

Authors:  J J Michiels; J Abels; J Steketee; H H van Vliet; V D Vuzevski
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

10.  Autonomic innervation of the skin in primary erythermalgia.

Authors:  H Uno; F Parker
Journal:  Arch Dermatol       Date:  1983-01
View more
  19 in total

1.  Revised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2.

Authors:  Maurine R Hobbs; Irving B Rosen; Charles E Jackson
Journal:  Am J Hum Genet       Date:  2002-05       Impact factor: 11.025

2.  A nonsense mutation in the SCN9A gene in congenital insensitivity to pain.

Authors:  Mazen Kurban; Muhammad Wajid; Yutaka Shimomura; Angela M Christiano
Journal:  Dermatology       Date:  2010-07-13       Impact factor: 5.366

3.  A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief.

Authors:  Jun-Ho Lee; Chul-Kyu Park; Gang Chen; Qingjian Han; Rou-Gang Xie; Tong Liu; Ru-Rong Ji; Seok-Yong Lee
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

Review 4.  Toward a Mechanism-Based Approach to Pain Diagnosis.

Authors:  Daniel Vardeh; Richard J Mannion; Clifford J Woolf
Journal:  J Pain       Date:  2016-09       Impact factor: 5.820

5.  Characterization of a familial case with primary erythromelalgia from Taiwan.

Authors:  Ming-Jen Lee; Hsin-Su Yu; Sung-Tsang Hsieh; Dennis A Stephenson; Chien-Jung Lu; Chih-Chao Yang
Journal:  J Neurol       Date:  2007-02-08       Impact factor: 4.849

6.  Evidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndromes.

Authors:  Anne Louise Oaklander; Max M Klein
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

Review 7.  Challenges in the development of novel treatment strategies for neuropathic pain.

Authors:  Michael H Ossipov; Frank Porreca
Journal:  NeuroRx       Date:  2005-10

Review 8.  Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.

Authors:  Joost P H Drenth; Stephen G Waxman
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodies.

Authors:  Sangsu Bang; Jiho Yoo; Xingrui Gong; Di Liu; Qingjian Han; Xin Luo; Wonseok Chang; Gang Chen; Sang-Taek Im; Yong Ho Kim; Judith A Strong; Ma-Zhong Zhang; Jun-Ming Zhang; Seok-Yong Lee; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2018-01-15       Impact factor: 5.203

Review 10.  Sodium channelopathies and pain.

Authors:  Angelika Lampert; Andrias O O'Reilly; Peter Reeh; Andreas Leffler
Journal:  Pflugers Arch       Date:  2010-01-26       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.